Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists
- PMID: 29846502
- DOI: 10.1093/annonc/mdy166
Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists
Abstract
Background: Deep learning convolutional neural networks (CNN) may facilitate melanoma detection, but data comparing a CNN's diagnostic performance to larger groups of dermatologists are lacking.
Methods: Google's Inception v4 CNN architecture was trained and validated using dermoscopic images and corresponding diagnoses. In a comparative cross-sectional reader study a 100-image test-set was used (level-I: dermoscopy only; level-II: dermoscopy plus clinical information and images). Main outcome measures were sensitivity, specificity and area under the curve (AUC) of receiver operating characteristics (ROC) for diagnostic classification (dichotomous) of lesions by the CNN versus an international group of 58 dermatologists during level-I or -II of the reader study. Secondary end points included the dermatologists' diagnostic performance in their management decisions and differences in the diagnostic performance of dermatologists during level-I and -II of the reader study. Additionally, the CNN's performance was compared with the top-five algorithms of the 2016 International Symposium on Biomedical Imaging (ISBI) challenge.
Results: In level-I dermatologists achieved a mean (±standard deviation) sensitivity and specificity for lesion classification of 86.6% (±9.3%) and 71.3% (±11.2%), respectively. More clinical information (level-II) improved the sensitivity to 88.9% (±9.6%, P = 0.19) and specificity to 75.7% (±11.7%, P < 0.05). The CNN ROC curve revealed a higher specificity of 82.5% when compared with dermatologists in level-I (71.3%, P < 0.01) and level-II (75.7%, P < 0.01) at their sensitivities of 86.6% and 88.9%, respectively. The CNN ROC AUC was greater than the mean ROC area of dermatologists (0.86 versus 0.79, P < 0.01). The CNN scored results close to the top three algorithms of the ISBI 2016 challenge.
Conclusions: For the first time we compared a CNN's diagnostic performance with a large international group of 58 dermatologists, including 30 experts. Most dermatologists were outperformed by the CNN. Irrespective of any physicians' experience, they may benefit from assistance by a CNN's image classification.
Clinical trial number: This study was registered at the German Clinical Trial Register (DRKS-Study-ID: DRKS00013570; https://www.drks.de/drks_web/).
Comment in
-
Artificial intelligence for melanoma diagnosis: how can we deliver on the promise?Ann Oncol. 2019 Dec 1;30(12):e1-e3. doi: 10.1093/annonc/mdy191. Ann Oncol. 2019. PMID: 29790922 No abstract available.
-
Artificial intelligence for melanoma diagnosis: how can we deliver on the promise?Ann Oncol. 2018 Aug 1;29(8):1625-1628. doi: 10.1093/annonc/mdy193. Ann Oncol. 2018. PMID: 29846499 No abstract available.
-
What type of man against machine?Ann Oncol. 2018 Sep 1;29(9):2023-2024. doi: 10.1093/annonc/mdy235. Ann Oncol. 2018. PMID: 29982274 No abstract available.
-
Reply to the letter to the editor 'What type of man against machine?' by H. Smith.Ann Oncol. 2018 Sep 1;29(9):2024-2025. doi: 10.1093/annonc/mdy237. Ann Oncol. 2018. PMID: 29992324 No abstract available.
-
Reply to 'Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists' by Haenssle et al.Ann Oncol. 2019 May 1;30(5):854. doi: 10.1093/annonc/mdy519. Ann Oncol. 2019. Retraction in: Ann Oncol. 2019 Feb 1;30(2):130e. doi: 10.1093/annonc/mdy520. PMID: 30535295 Retracted. No abstract available.
-
Reply to the letter to the editor 'Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists' by H. A. Haenssle et al.Ann Oncol. 2019 May 1;30(5):854-857. doi: 10.1093/annonc/mdz015. Ann Oncol. 2019. PMID: 30689691 No abstract available.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
